Outcomes in Ethnic Minority Renal Transplant Recipients Receiving Everolimus versus Mycophenolate: Comparative Risk Assessment Results From a Pooled Analysis

BACKGROUND: Everolimus (EVR) has demonstrated good efficacy after renal transplantation. Racial disparities in clinical outcomes after de novo renal transplantation are well documented; whether the efficacy of EVR varies based on recipient ethnicity is unknown. We conducted a comparative risk assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Melancon, Keith, Mulgaonkar, Shamkant P., Delcoro, Carlos, Wiland, Anne, McCague, Kevin, Shihab, Fuad S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2013
Materias:
Clinical and Translational Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888463/
https://www.ncbi.nlm.nih.gov/pubmed/24345868
http://dx.doi.org/10.1097/TP.0b013e3182a486f5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888463/
https://www.ncbi.nlm.nih.gov/pubmed/24345868
http://dx.doi.org/10.1097/TP.0b013e3182a486f5

Ejemplares similares